Lichen planus pemphigoides: A unique form of bullous and lichenoid eruptions secondary to nivolumab
Author:
Affiliation:
1. Department of Dermatology Rutgers New Jersey Medical School Newark New Jersey USA
2. Department of Dermatology ProPath Dallas Texas USA
3. St. Lawrence Health System Clarkson University Postdam New York USA
Publisher
Hindawi Limited
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15432
Reference25 articles.
1. The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers
2. Safety and Activity of Programmed Cell Death 1 Versus Programmed Cell Death Ligand 1 Inhibitors for Platinum-Resistant Urothelial Cancer: A Meta-Analysis of Published Clinical Trials
3. Cutaneous toxicities of immune checkpoint inhibitors: the role of the dermatologist;Tattersall IW;Yale J Biol Med,2020
4. BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid
5. A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Giant renal cell carcinoma in a patient with ipsilateral lower limb hypertrophic lichen planus; Case report and literature review;Journal of Mind and Medical Sciences;2023-10-31
2. Pembrolizumab-Induced Lichen Planus Pemphigoides in a Patient with Metastatic Adrenocortical Cancer: A Case Report and Literature Review;Dermatopathology;2023-08-15
3. Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience;Frontiers in Medicine;2023-07-20
4. Mucocutaneous adverse events to immune checkpoint inhibitors;Frontiers in Allergy;2023-03-02
5. Lichen Planopilaris Pemphigoides: A Novel Bullous Dermatosis Due to Programmed Cell Death Protein-1 Inhibitor Therapy;The American Journal of Dermatopathology;2023-02-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3